Human and mouse ®broblasts with normal p53 fail to enter mitosis when DNA synthesis is blocked by aphidicolin or hydroxyurea. Isogenic p53-null ®broblasts do enter mitosis with incompletely replicated DNA, revealing that p53 contributes to a checkpoint that ensures that mitosis does not occur until DNA synthesis is complete. When treated with N-(phosphonacetyl)-Laspartate (PALA), which inhibits pyrimidine nucleotide synthesis, leading to synthesis of damaged DNA from highly unbalanced dNTP pools, p53-null cells enter mitosis after they have completed DNA replication, but cells with wild-type p53 do not, revealing that p53 also mediates a checkpoint that monitors the quality of newly replicated DNA.
Introduction
Cell cycle progression is regulated at checkpoints, where the proper completion of early events is assessed before later events are initiated. For example, entry into mitosis is strictly dependent on the completion of DNA synthesis (Nurse, 1994; Hartwell and Weinert, 1989) . Genetic analysis of S. pombe and S. cerevisiae had uncovered proteins involved in several aspects of this checkpoint (Elledge, 1996) . Strains of S. cerevisiae with a mutant form of polymerase x enter mitosis in the presence of unreplicated DNA, leading to chromatin fragmentation with accompanying loss of viability (Navas et al., 1995) . Therefore, DNA polymerase may sense the progress of DNA synthesis, a function that may be shared by the S. pombe gene cut5 (Elledge, 1996; Saka and Yanagida, 1993) . Entry into mitosis when DNA synthesis is blocked is also observed in S. cerevisiae strains carrying a mutant allele of mec1, which has homology to the human atm gene, or rad53, which encodes a protein kinase that is phosphorylated and activated when DNA synthesis is arrested (Weinert et al., 1994; Allen et al., 1994; Kato and Ogawa, 1994; Savitsky et al., 1995; Stern et al., 1991) . Therefore, MEC1 and RAD53 may transduce the signal generated by blocking DNA synthesis to the cell cycle machinery (Elledge, 1996) . The mitotic regulator CDC2 may function as an eector of this checkpoint since S. pombe mutants in MIK1 and WEE1, negative regulators of CDC2, also enter mitosis with unreplicated DNA (Lundgren et al., 1991) . Tyrosine phosphorylation of CDC2 is important in inhibiting mitosis when DNA synthesis is blocked in S. pombe and X. laevis but not in S. cerevisiae (Enoch and Nurse, 1990; Smythe and Newport, 1992; Sorger and Murray, 1992) .
In mammalian cells, the coupling between mitosis and DNA synthesis can be overcome by overexpressing CDC2/CYCLIN B, by mutation of the RCC1 nucleotide exchange factor, by overexpressing SV40 large T antigen, or by treating cells with inhibitors of protein kinases or phosphatases (Heald et al., 1993; Jin et al., 1996; Krek and Nigg, 1991; Nishitani et al., 1991; Schlegel and Pardee, 1986; Steinmann et al., 1991; Chang et al., 1997) . Regulation of mitotic entry after exposure of mammalian cells to UV or ionizing radiation appears to involve inhibitory phosphorylation of CDC2 (Herzinger et al., 1995; Poon et al., 1996) . Inhibition of CDC2 in response to DNA damage also involves inhibitory phosphorylation of the CDC2 activator CDC25 by CHK1, a kinase that is modi®ed in response to ionizing radiation (Furnari et al., 1997; Peng et al., 1997; Sanchez et al., 1997) . It is not known if mitotic inhibition in mammalian cells in response to UV or ionizing radiation occurs by the same mechanism that responds to inhibition of DNA synthesis.
p53 is essential for maintaining genomic stability, helping to protect mammals from neoplasia (reviewed in Agarwal et al., 1998b; Levine, 1997; Ko and Prives, 1996; Lane, 1992) . Homozygous or heterozygous inactivation of p53 in mice or heterozygous inactivation in humans predisposes to neoplasia, and mutation of p53 occurs in over half of all spontaneous human tumors (Donehower et al., 1992; Li and Fraumeni, 1969; Srivastava et al., 1990; Greenblatt et al., 1994) . In response to DNA damage, p53 is stabilized and activated to bind to speci®c DNA sequences, where it drives the transcription of genes involved in cell cycle arrest and apoptosis (Fritsche et al., 1993; Hupp et al., 1995; El-Deiry et al., 1993; Dulic et al., 1994; Miyashita and Reed, 1995; Attardi et al., 1996; Agarwal et al., 1997) . p53 is also activated in response to stimuli that do not generate broken DNA directly, including nucleotide deprivation and hypoxia (Linke et al., 1996; Graeber et al., 1996; Agarwal et al., 1997) . The cell cycle is regulated at several points by p53, which is required to inhibit entry into S phase in response to either DNA damage or the arrest caused by inhibitors of microtubule assembly, and the latter function links the loss of p53 to aneuploidy (Kastan et al., 1991; Dulic et al., 1994; Cross et al., 1995) . A role in the regulation of mitotic progression has been suggested by the observation that overexpression of p53 in the absence of any stress can cause G2/M arrest (Stewart et al., 1995; Agarwal et al., 1995) . This function, along with the observation that p53 can be activated by agents that block DNA synthesis (Khanna and Lavin, 1995; Linke et al., 1996) , suggested that p53 might be involved in coupling mitotic entry to the completion of DNA synthesis. We tested this idea by scoring the ability of normal and p53-null ®broblasts to enter mitosis after treatment with inhibitors of DNA synthesis, and ®nd that p53 contributes to the regulation of mitotic entry under two dierent conditions: when DNA synthesis is completely blocked or when DNA is synthesized slowly from highly unbalanced nucleotide pools.
Results

p53-null cells enter mitosis when DNA synthesis is blocked by hydroxyurea
We analysed entry into mitosis in normal and p53-null human and mouse cells when DNA synthesis was inhibited with aphidicolin (which blocks DNA polymerase), hydroxyurea (which blocks ribonucleotide reductase) or N-(phosphonacetyl)-L-aspartate (PALA, an inhibitor of de novo pyrimidine nucleotide biosynthesis). In the experiments described ®rst, time-lapse analysis was used to determine the ability of human ®broblasts with or without p53 to enter mitosis in the presence of hydroxyurea. To obtain isogenic cell lines diering only in p53 status, we introduced wild-type p53 into the human Li-Fraumeni ®broblast cell line MDAH041, which is hemizygous for a truncated p53 allele and expresses no detectable p53 protein (Yin et al., 1992) . The resulting TR9-7 cells, which express wild-type p53 from a tetracycline-regulated promoter, were grown in the presence of tetracycline, which leads to low level p53 expression, similar to the normal diploid ®broblast cell strain WI38 Agarwal et al., 1998a) . Cells growing in normal medium were ®lmed for 16 h to determine the normal mitotic index. Hydroxyurea was then added and the cells were ®lmed for 3 days. In the 16 h before adding hydroxyurea, 29% of MDAH041 and 26% of TR9-7 cells progressed through mitosis, showing that both cell lines grow at a similar rate. MDAH041 and TR9-7 cells traverse G2 and M in approximately 4.4 and 4.5 h, respectively (determined by comparing the cell cycle length with the fraction of cells in G2/M; Figure  1 ). We excluded from the analysis cells that entered mitosis during the intervals corresponding to the length of G2 plus M following the addition of hydroxyurea since these cells, beyond S-phase, would not be aected by the drug.
Many MDAH041 cells continued to attempt mitosis in hydroxyurea, but the TR9-7 cells did not ( Figure  1a ). To con®rm that this result was not due to eects of tetracycline, we used time-lapse video microscopy to analyse human C11 cells, derived from MDAH041 by stable expression of a wild-type p53 minigene (Agarwal et al., 1998a) . These cells, which express a lower basal level of p53 than TR9-7 cells, showed a 40% decrease in mitotic entry in the presence of hydroxyurea compared to MDAH041 cells (Agarwal et al., 1998a and data not shown). Also, time lapse observation for Figure 1 Time-lapse analysis of mitosis when DNA synthesis is blocked. Under each condition, 100 cells were observed to determine the cumulative mitotic index. Mitosis was scored as described in Materials and methods. In (a) and (b), cells were ®lmed and mitosis was analysed for 16 h before adding hydroxyurea to compare rates of growth. Mitoses were scored after all the cells that were already in G2 and M when hydroxyurea was added had progressed through mitosis. The times required to pass through G2 and M (determined by comparing the cell cycle length with the fraction of cells in G2/M, as assessed by FACScanning) was as follows: MDAH041: 4.4 h; TR9-7: 4.5 h; p537/7 MEFs: 2.3 h; p53+/+ MEFs: 3.2 h (Harvey et al., 1993; Agarwal et al., 1998a; and data not shown) . (a) Time-lapse analysis of mitosis in individual p53-null MDAH041 cells, and p53-reconstituted TR9-7 cells in 2 mM hydroxyurea. (b) Time-lapse analysis of mitosis in individual normal and p53-null MEFs in 2 mM hydroxyurea. (c) Time-lapse analysis of mitosis in human cells in PALA. WI38 or MDAH041 cells were treated with 500 mM PALA for 72 h and analysed for an additional 21 h in the continued presence of PALA 72 h revealed that only one out of 61 WI38 cells entered mitosis 5 h (length of G2 plus M) after adding hydroxyurea to a logarithmically growing culture. Furthermore, Gossen and Bujard (1992) were unable to detect changes in morphology or growth of human cells treated with tetracycline alone. Our results suggest that p53 is required to inhibit entry into mitosis when DNA synthesis is blocked.
Most (25 out of 30; 83%) of the MDAH041 cells that entered mitosis in hydroxyurea completed cytokinesis to form two independent daughter cells, showing that the events observed were surely mitoses. The ®ve of 30 (17%) hydroxyurea-treated mitotic MDAH041 cells that failed to undergo cytokinesis entered metaphase with a rounded morphology and then, without formation of a cleavage furrow, reestablished contact with the substratum and again acquired a¯attened interphase morphology. Two of 44 (4.5%) untreated mitotic MDAH041 cells behaved similarly. This aborted mitosis was also observed frequently in p53-null mouse embryo ®broblasts (MEFs) treated with hydroxyurea (see below). All of the MDAH041 cells that entered mitosis in hydroxyurea did so only once during the 3-day ®lming period.
Time-lapse analysis was also used to determine the ability of normal and p53-null MEFs to enter mitosis in the presence of hydroxyurea. Thirty-two per cent of normal and 66% of p53-null MEFs entered mitosis during the 16 h period before the drug was added, re¯ecting their dierent growth rates. As before, the time-lapse analysis was begun when cells already in G2 or M at the time hydroxyurea was added had completed mitosis. Entry of the p53-null cells into mitosis continued in hydroxyurea, with a total of 19% of the cells attempting mitosis during 3 days. In contrast, normal MEFs were almost completely blocked from entering mitosis after exposure to hydroxyurea (Figure 1b) . The time between exposure of the p53-null MEFs to hydroxyurea and their entry into mitosis was variable, with some cells remaining arrested for up to 60 h before entering mitosis and others entering mitosis only 12 h after adding hydroxyurea. Similarly to the human cells, almost all (16 out of 17) of the p53-null MEFs that entered mitosis 2.3 h or more after exposure to hydroxyurea did so only once during the 3-day ®lming period. Therefore, many p53-null cells continue to enter mitosis in the presence of hydroxyurea but, unlike the situation in most checkpoint-defective yeast strains, the interval between adding the drug and entry into mitosis was variable and typically much longer than the normal length of S.
In contrast to the results with p53-null human ®broblasts, very few of the p53-null MEFs that entered mitosis after exposure to hydroxyurea could complete this process to produce daughter cells. Figure 2 shows an example of a normal mitosis and two aborted mitotic events. Cell`a' enters metaphase 35 h and 50 min after adding hydroxyurea. It has the same rounded morphology for 1 h and 23 min, after which it ®rst shows evidence of reattachment to the substratum. Cell`b' enters metaphase 47 h and 47 min after adding hydroxyurea and begins to re-attach 2 h and 13 min later. Whereas four of 70 (6%) untreated p53-null MEFs and 14 of 74 (19%) untreated normal MEFs aborted mitosis, 16 of 17 (94%) of the hydroxyureatreated p53-null MEFs that entered mitosis did not undergo cytokinesis.
In some cases, abortive mitoses resulted in the formation of micronuclei (Figure 2 ) and, in general, entry into mitosis before the completion of DNA synthesis would be expected to lead to cell death. Therefore, we analysed the eect of p53 loss on survival following treatment with hydroxyurea. The relative colony forming ability of TR9-7 cells after exposure to 2 mM hydroxyurea for 96 h was 73%, whereas that of MDAH041 cells was less than 1% (data not shown). Thus, p53 is required for cell survival when DNA synthesis is blocked.
p53-null cells that enter mitosis when DNA synthesis is blocked have mitotic spindles, condensed chromosomes, and high levels of phosphorylated histone H1b
We used immuno¯uorescence to characterize more fully the mitotic events observed when DNA synthesis was blocked in cells lacking p53. Since time-lapse analysis showed that p53-null cells entered mitosis at variable times after adding hydroxyurea and that these mitoses occurred only once during the ®lming period, we examined populations of cells 48 or 72 h after inhibiting DNA synthesis, to analyse cells attempting mitosis for the ®rst time after DNA synthesis was inhibited. Similar results were obtained at either time. First, normal and p53-null MEFs were treated with aphidicolin or hydroxyurea and ®xed cells were analysed with antibodies to a-tubulin, to detect mitotic spindles, with antibodies to phosphorylated histone H1b (pH1b) (which is expressed highly only in mitotic cells), and with 4, 6-diamidino-2-phenylindole (DAPI) to detect DNA (Lu et al., 1994; Chadee et al., 1995) . In each experiment, 1000 cells from approximately 200 randomly selected ®elds were examined for these mitotic markers. Since few cells are in mitosis in any one time in asynchronous cultures and since the rate of entry into mitosis is suppressed in p53-null cells treated with hydroxyurea ( Figure 1a and b and our unpublished observations), we observed only a few cells (0.2 ± 0.5%) in mitosis in the presence of the drug. Normal MEFs treated with aphidicolin or hydroxyurea failed to enter mitosis ( Figure 3a ). They had low levels of pH1b which was always con®ned to nuclei with interphase morphology (Figure 3b and data not shown). Furthermore, no mitotic spindles were observed ( Figure 3b ). In contrast, some p53-null MEFs did show evidence of mitosis when treated with the inhibitors (Figure 3a) . Entry into mitosis, either in untreated cultures or when DNA synthesis was blocked, was characterized by the presence of condensed chromosomes, mitotic spindles, and high levels of pH1b distributed throughout the cytoplasm, indicating disassembly of the nuclear membrane ( Figure 3b ; Lu et al., 1994; Chadee et al., 1995) . For example, when treated for 48 h with hydroxyurea, 0.2% of the p53-null MEFs entered mitosis with the full set of characteristics ( Figure 3a ,b), compared to 0.9% of the untreated p53-null MEFs. When treated with aphidicolin or hydroxyurea for 72 h, 0.4 or 0.5% of p53-null MEFs entered mitosis. Similarly to a recent report, we observed that *30% of the p53-null cells that entered mitosis in the absence of treatment or when DNA synthesis was blocked contained more than two spindle poles (Fukasawa et al., 1996; see Figures 3b and 5b for examples).
We also analysed p53-null MDAH041 cells and WI38 cells which have wild-type p53 and normal responses to activation of p53 (Yin et al., 1992) . The WI38 cells did not enter mitosis after 48 or 72 h of treatment with aphidicolin or hydroxyurea (Figure 3a , c). Similarly to normal MEFs, these cells had low levels of pH1b, the morphology of their nuclei was characteristic of interphase cells, and mitotic spindles were absent (Figures 3c, 5c , and data not shown). In contrast, MDAH041 cells continued to enter mitosis in the presence of both inhibitors (Figure 3a) , with high levels of cytoplasmic pH1b, condensed chromosomes, and mitotic spindles. We observed that 0.2% of MDAH041 cells entered mitosis when treated with hydroxyurea for 48 h compared to 2.0% without such treatment ( Figure 3a) . Similarly, when treated for 72 h, 0.2 or 0.1% of the MDAH041 cells entered mitosis when treated with aphidicolin or hydroxyurea, respectively ( Figure 3a ). Double immunostaining showed that the majority (27 out of 33; 82%) of hydroxyureatreated MDAH041 cells that contained high levels of pH1b also contained spindles (see Figure 3d for examples), con®rming the mitotic speci®city of the antibody to pH1b. Western analysis con®rmed that p53 was induced by inhibitors of DNA synthesis in WI38 cells (Figure 4 ), normal MEFs (data not shown) and C11 and TR9-7 cells (Agarwal et al., 1998a) . Induction of p53 by inhibitors of DNA synthesis has been observed in other cell types (Khanna and Lavin, 1995; Paulson et al., 1998) .
To determine if the p53 induced by inhibitors of DNA synthesis is transcriptionally active, HT1080 cells, with wild-type p53, were stably transfected with a luciferase reporter under the control of the conA p53 binding element (Funk et al., 1992) . Treatment of these cells with 2 mM hydroxyurea for 48 h led to a 5.9-fold increase in luciferase activity. Furthermore, the p21/ waf1/cip1 protein was induced 2.3-and 2.2-fold by Figure 2 Examples of aborted mitosis in p53-null MEFs treated with hydroxyurea. Frames from a time-lapse ®lm are shown. The top series of panels show a normal mitosis which occurred immediately after drug addition. This cell was presumably in G2 when hydroxyurea was added. The middle series of panels show two adjacent cells that undergo an abortive mitosis. Frames were taken every 1000 s (16 min, 40 s) and only the most informative frames are shown treating p53+/+ MEFs with 2 mM hydroxyurea or 500 mM PALA for 48 h, respectively (data not shown).
Chromatin fragmentation in p53-null cells that enter mitosis when DNA synthesis is blocked When treated with aphidicolin for 72 h, 12 of 31 (39%) mitotic MDAH041 cells, marked by a high level of cytoplasmic pH1b, also contained extensively fragmented chromatin (Figure 5a ). In contrast, fragmented chromatin was not observed in 100 untreated mitotic MDAH041 cells. In some cells, the chromatin was fragmented and in others it was highly condensed and dispersed into disorganized patches (Figure 5a ). These phenotypes were observed at similar frequencies when MDAH041 cells were treated with aphidicolin for Figure 3 Inappropriate entry into mitosis in ®broblasts lacking p53. Cells were treated with aphidicolin (Aph, 5 mg/ml), hydroxyurea (Hu, 2 mM) or PALA (500 mM) for 48 or 72 h. Fixed cells were analysed by immuno¯uorescence using antibodies to pH1b or a-tubulin, to detect mitotic spindles. (a) Frequency of mitosis in p53-null ®broblasts when DNA synthesis is blocked. Cells containing both high levels of pH1b and condensed chromosomes were scored as mitotic. Bars on the base line represent fewer than one mitotic cell per 1000. When we pooled all the results we found that normal (WI38 and p53+/+ MEFs) and p53-null (MDAH041 and p537/7 MEFs) were signi®cantly dierent with regard to mitotic entry when DNA synthesis was blocked (P value 50.05). Figure  5c ). The coincidence of chromatin fragmentation with mitotic spindles con®rms that the mitotic events that do occur are aberrant and suggests that the p53-null cells have entered mitosis with incompletely replicated DNA (Lundgren et al., 1991; Heald et al., 1993; Schlegel and Pardee, 1986; Steinmann et al., 1991) .
p53-null cells that enter mitosis when DNA synthesis is blocked contain less than 4 N DNA If loss of p53 inactivates the checkpoint that monitors the completion of DNA synthesis, some p53-null cells that enter mitosis should contain a complement of DNA of less than 4 N. To examine this issue directly, we measured both pH1b, which marks cells in mitosis, and the DNA contents of individual cells in a twoparameter FACScan assay. In each experiment, 20 000 cells were analysed. Without treatment, 2.6% of MDAH041 cells showed high levels of pH1b, and the majority of such cells contained a 4 N complement of DNA (Figure 6a ). When WI38 cells were treated with aphidicolin or hydroxyurea, entry into mitosis was abolished (data not shown), whereas similarly treated MDAH041 cells continued to enter mitosis (Figure 6a ). In the presence of hydroxyurea or aphidicolin, as many as 60% of the MDAH041 cells that entered mitosis contained less than a 4 N complement of DNA ( Figure  6a,b) . Similar results were obtained when mitotic events were analysed in normal and p53-null MEFs (data not shown). When analysed for DNA content alone, hydroxyurea-arrested MDAH041 and WI38 cells showed very similar cell cycle distributions (Figure 6c ). Since aphidicolin and hydroxyurea do not aect cells outside of S phase, the fraction of the cells that are in G2, M or G1 when the drug is added will progress to the G1/S boundary. DNA synthesis, as determined by the incorporation of BrdU, was blocked completely by hydroxyurea or aphidicolin (Figure 6d ). Our experiments with aphidicolin and hydroxyurea show that p53 plays an important role in inhibiting entry into mitosis when DNA synthesis is blocked completely, but do not reveal whether p53 is involved in regulating mitosis in cells that have completed DNA synthesis under conditions that favor DNA damage, such as nucleotide imbalance. To address this point, we analysed mitotic entry in normal and p53-null cells in the presence of PALA, which depletes pyrimidine deoxynucleotide pools, leading to the synthesis of damaged DNA (Di Leonardo et al., 1993; Chernova et al., 1995) . Using immuno¯uorescence, we obtained similar results with both human and mouse cells. Timelapse video microscopy was used to analyse mitotic events in PALA-treated normal and p53-null human cells (Figure 1c ). MDAH041 and WI38 cells were treated with PALA for 72 h and then ®lmed for 21 h in the continued presence of PALA. In MDAH041 cells, a substantial number of mitotic events continued to occur 72 ± 93 h after adding PALA, but there were very few such events in similarly treated WI38 cells ( Figure  1c ). During this interval in PALA, 27% of MDAH041 cells entered mitosis, compared to only 3% of WI38 cells. The MDAH041 cells entered mitosis asynchronously ( Figure 1c) and all of the p53-null cells that entered mitosis in PALA completed cytokinesis within 2 ± 3 h (data not shown). Cell death in PALA was much more frequent in MDAH041 than in WI38 cells (Yin et al., 1992 and our unpublished observations) . Mitotic entry in C11 cells was decreased by 60% when treated with PALA for 72 h, compared to parental p53-null MDAH041 cells (data not shown). The fact that re-expression of p53 in MDAH041 cells substantially reduces entry into mitosis con®rms our conclusion that the regulation of mitotic entry under these conditions is p53-dependent.
Immuno¯uorescence analysis showed that, as with aphidicolin and hydroxyurea, PALA-treated normal human and mouse cells failed to enter mitosis ( Figure  3a) , showing low levels of pH1b and lacking condensed chromosomes and mitotic spindles (Figure 3b,c) . However, p53-null human and mouse cells both did enter mitosis in PALA, with high levels of cytoplasmic pH1b, condensed chromosomes and mitotic spindles (Figure 3b,c) . When treated for 48 or 72 h with PALA, 0.5 or 2.0% of MDAH041 cells and 0.4 or 1.1% of p53-null MEFs entered mitosis, respectively (Figure 3a) . In summary, p53-null cells enter and complete mitosis in PALA whereas normal cells do not.
p53-null cells that enter mitosis in PALA have completed DNA synthesis
Unlike cells treated with hydroxyurea, the majority of p53-null MDAH041 cells that entered mitosis when treated with PALA had a 4 N complement of DNA (Figure 6a ). PALA-treated WI38 cells failed to enter mitosis and similar results were obtained with normal and p53-null MEFs (data not shown). To understand the basis of these observations, we analysed cell-cycle distributions and the incorporation of BrdU in the presence of PALA. WI38 cells treated with PALA for 72 h accumulated in G1 and G2/M, whereas PALAtreated MDAH041 cells were distributed throughout Sphase (Figure 6c) . Also, as previously observed (Di Leonardo et al., 1993) , most MDAH041 cells incorporate BrdU in the presence of PALA (Figure 6d) . A likely possibility is that these cells make pyrimidine deoxynucleotide precursors of DNA from internal pools such as ribosomal RNA. PALA-treated WI38 cells continued to incorporate BrdU for 24 h, but stopped by 48 or 72 h (Figure 6d and White et al., 1996) . Twenty-four hours after adding PALA, *37% of WI38 cells were still in Sphase (White et al., 1996 and our unpublished data) . Those WI38 cells that are in S phase when PALA is added presumably complete DNA synthesis within 72 h by utilizing salvage pathways, but are blocked in G2/M due to a p53-dependent checkpoint. WI38 cells in G1 do not enter S phase due to the well known p53-dependent G1 arrest in response to nucleotide deprivation (Linke et al., 1996) . MDAH041 cells, which lack this G1 arrest, proceed slowly through S phase when treated with PALA. Synthesis of DNA under conditions of nucleotide imbalance favors the generation of DNA damage (Di Leonardo et al., 1993; Chernova et al., 1995) and our FACScan results show that those MDAH041 cells that do complete DNA synthesis under such conditions do go on to enter mitosis.
Overexpression of p53 inhibits entry into mitosis in the absence of any stress
Our analysis of normal and p53-null cells illustrates the importance of p53 in maintaining normal control over mitotic entry and suggests that blocking DNA synthesis activates p53, enabling it to inhibit entry into mitosis. To determine whether overexpression of p53 in the absence of stress can also inhibit entry into mitosis, we used TR9-7 cells, which have a tetracyclineregulated p53 minigene stably integrated in MDAH041 cells. Induction of p53 in logarithmically growing TR9-7 cells caused primarily a G1 arrest . However, overexpression of p53 following release of TR9-7 cells from a mimosine-imposed block at the beginning of S phase (past the G1 arrest point), led to the accumulation of cells with a G2/M content of DNA . To determine the position of this G2/M checkpoint more precisely, we stained the arrested cells with antibodies to pH1b and with DAPI. Cells arrested in S phase with mimosine (Hughes and Cook, 1996) contained very low levels of pH1b (Figure 7a ). When observed 48 h after release from the mimosine block, the level of pH1b and the cell cycle distribution were almost indistinguishable in cells in which the p53 minigene was repressed (in tetracycline) and in untreated cells (in tetracycline without mimosine). When released from the block without tetracycline (high p53 content), the cells had nearly undetectable levels of pH1b and did not contain condensed chromosomes (Figure 7a and data not shown). FACScan analysis of cells from the same experiment showed that 56% had a 4 N (G2/M) content of DNA (Figure 7a ), revealing that p53 alone inhibits the ability of cells to reach an early stage of mitosis.
Mitosis in mammalian cells is regulated primarily by the cyclin-dependent protein kinase CDC2. Activation of pre-assembled complexes of CDC2 and cyclin B by caeine can overcome inhibition of entry into mitosis under a number of conditions (Schlegel and Pardee, 1986; Hain et al., 1993) . To test whether the mechanism of p53-dependent G2 arrest might involve regulation of CDC2, cells synchronously traversing S Figure 7 Inhibition of mitotic entry by p53 and abrogation of this eect by caeine. TR9-7 cells, derived from a p53-null Li Fraumeni ®broblast cell line and containing a tetracycline-inducible p53 minigene , were synchronized at the beginning of S phase with mimosine. (a) Forty-eight hours after removing mimosine, with (low p53) or without tetracycline (high p53), the cells were analysed for pH1b by immuno¯uorescence and for DNA content by FACScanning. Release in the absence of tetracycline leads to the arrest of *60% of TR9-7 cells in G2/M . (b) Cells treated as in (a) were collected 72 h after removing mimosine in the presence or absence of tetracycline and 5 mM caeine phase with high levels of p53 were treated with 5 mM caeine. Caeine abrogated the p53-dependent G2 arrest very eciently (Figure 7b ), consistent with an involvement of CDC2 in this cell cycle block.
Discussion
As shown schematically in Figure 8 , p53 regulates several distinct cell-cycle processes. It mediates G1 arrest in response to DNA damage by inducing p21/ waf1/cip1, which inhibits the activity of cyclindependent kinases such as CDK2, required to drive G1 progression (Kastan et al., 1991; Dulic et al., 1994) . p53 also inhibits the re-replication of DNA after damage to the mitotic spindle, a function that appears to depend on the ability of p53 to block entry into Sphase (Cross et al., 1995; Minn et al., 1996; Di Leonardo et al., 1997) . In addition, p53-null cells show alterations in centrosome homeostasis (Fukasawa et al., 1996) . We now show that p53 is required to block mitosis when DNA synthesis is inhibited or when DNA is synthesized under unfavorable conditions. It is intriguing that acute overexpression of SV40 large T antigen or HPV E6 in human diploid ®broblasts overcomes several checkpoints regulating mitotic entry in response to damaged or incompletely replicated DNA Thompson et al., 1997) . This eect is probably due to the ability of these viral antigens to inactivate p53 and is consistent with our results.
Our experiments with hydroxyurea and aphidicolin reveal an important aspect of cell cycle control by p53. Inhibition of ribonucleotide reductase (by hydroxyurea) or of DNA polymerase (by aphidicolin) stops any cell from making DNA and, in the presence of either of these drugs, both normal and p53-null cells have a complement of DNA between 2 and 4 N (Figure 6c ). In this situation, p53 helps to ensure that cells that cannot complete DNA synthesis do not enter mitosis. Time-lapse microscopy revealed that p53-null cells entered mitosis at variable times after exposure to hydroxyurea, and did so only once. Furthermore, many of the cells that did enter mitosis spent more time than normal in this phase of the cell cycle (data not shown). Although p53 is required for the proper coupling of DNA synthesis and mitosis, the phenotype observed upon loss of p53 is dierent from that observed in checkpoint-defective yeast strains, which tend to enter mitosis synchronously when DNA synthesis is blocked. Approximately 20% of both human and mouse p53-null cells attempted mitosis during 3 days in the presence of hydroxyurea. The reason that not all of the cells entered mitosis under these conditions is probably related to the toxicity of hydroxyurea for p53-null ®broblasts. Time-lapse analysis revealed that between 20 ± 30% of the p53-null human and mouse cells died instead of attempting mitosis (data not shown). Cell death, which occurred throughout the 3-day ®lming period, removed cells from the analysis of mitosis. However, a substantial number of cells (*50%) neither died nor attempted Figure 8 Regulation of cell cycle events by p53. p53, activated and induced by DNA damage or nucleotide deprivation (thick solid lines), arrests cells in G1 through a mechanism that depends on the CDK inhibitor p21/waf1/cip1 (Kastan et al., 1991; Dulic et al., 1994; Linke et al., 1996) . The p53-dependent spindle checkpoint (thin solid lines) ensures that cells do not re-enter S phase when blocked in mitosis (Cross et al., 1995) . The two checkpoints described in the present report (dashed lines) ensure that cells do not enter mitosis when DNA synthesis is blocked or when DNA synthesis has occurred in cells starved for pyrimidine nucleotides mitosis during this period. The presence of these arrested cells suggests that additional, p53-independent, mechanisms may inhibit premature entry into mitosis. The reduction in mitotic index was observed using both time-lapse analysis and immuno¯uorescence to examine p53-null cells treated with hydroxyurea (Figures 1, 3a , and our unpublished observations). However, comparison of the results obtained with these two methods is restricted since the mitotic index determined by immuno¯uorescence is in¯uenced by the proportion of cells that enter mitosis, the length of time that elapses before they enter mitosis and the duration of the mitotic event, all of which are altered in a hydroxyurea-treated culture.
Time-lapse analysis of mitotic events in hydroxyurea revealed the novel aspects of premature mitosis and lack of cytokinesis in p53-null MEFs. Very few of the MEFs that entered mitosis under these conditions could complete it and, after various times in metaphase, the cells re-entered interphase (Figure 2) , suggesting either that formation of the cleavage furrow in these cells depends on a physical structure generated during normal karyokinesis (Martineau et al., 1995) or that a p53-independent checkpoint maintains the dependency of cytokinesis on the proper completion of karyokinesis. Formation of cleavage furrows under these conditions also appears to be dependent on cellspeci®c factors, as most of the p53-null human ®broblasts did complete cytokinesis. Thus, the regulation of cell division may dier in rodent compared to human ®broblasts, or in embryonic (MEFs) compared to adult (MDAH041) ®broblasts. The molecular basis for this dierence is not known. We observed three MEF cells that underwent abortive mitosis and became micronucleated (Figure 2 ), presumably because the nuclear membrane formed again around misaligned groups of chromosomes or individual chromosomes. The formation of micronuclei is also consistent with the presence of mitotic cells with highly fragmented chromatin, as determined by immuno¯uorescence ( Figure 5 ). In the absence of p53, cells enter mitosis with incompletely replicated DNA, which is likely to cause chromatin fragmentation and micronucleation. It has recently been shown that the formation of micronuclei in cells treated with hydroxyurea is accelerated upon loss of p53 (Shimizu et al., 1998) . Although premature entry into mitosis upon loss of p53 may contribute to this eect, micronucleation was also observed during S phase, without a requirement for entry into mitosis (Shimizu et al., 1998) .
The premature entry into mitosis that we observed is likely to be responsible for the reduction in clonogenic survival induced by inhibitors of DNA synthesis in cells lacking p53. It has recently been found that the premature entry into mitosis caused by expression of a constitutively active CDC2 mutant protein sensitizes mammalian cells to the toxic eects of inhibitors of DNA synthesis (Blasina et al., 1997) . Whether this eect involves an apoptotic response is not known, but it is intriguing that we observed p53-null cells entering mitosis with high levels of pH1b, disassembled nuclear membranes, and highly condensed chromatin, similar to cells undergoing apoptosis (for a similar example see Chen et al., 1996) . It is possible that the loss of p53 allows premature entry into mitosis which, in some cells, leads to apoptosis.
Our experiments using PALA to deplete pyrimidine nucleotides has revealed that p53 also regulates entry into mitosis when DNA synthesis has been completed under unfavorable conditions. Our analysis of cell cycle distribution and BrdU incorporation (Figure 6 ), as well as data from other laboratories (White et al., 1996) , indicate that, in PALA-treated WI38 cells, DNA synthesis continues for a limited time at a reduced rate, probably due to the net synthesis of pyrimidine deoxynucleotides from internal pools such as rRNA through salvage pathways. By 72 h, DNA synthesis has ceased, due to the p53-mediated, p21/waf1/cip1-dependent block to S phase entry at the end of G1 (Di Leonardo et al., 1993; Linke et al., 1996; our unpublished data) . In normal cells that have attained a 4 N complement of DNA in the presence of PALA, we now ®nd that p53 inhibits entry into mitosis, causing them to accumulate in G2/M (Figure 6a,c) . This checkpoint prevents the segregation of DNA synthesized under conditions of nucleotide imbalance. In contrast, time-lapse analysis reveals that a major fraction of p53-null cells do enter and complete mitosis in the presence of PALA (Figure 1c and data not shown).
The loss of p53 in human ®broblasts confers permissivity for gene ampli®cation (Yin et al., 1992; Livingstone et al., 1992) . It is possible that the control of mitotic entry by p53 when DNA is synthesized under conditions of nucleotide imbalance is important in preventing DNA ampli®cation and the acquisition of PALA resistance. However, the mechanism may be complex. For example, treatment of normal diploid ®broblasts with PALA causes arrest primarily in G1, but there is also signi®cant arrest in G2 (White et al., 1996 and Figure 6c) . G1 arrest stops cells from attempting DNA synthesis when precursor pools are unbalanced, which would lead to DNA damage and thus to the generation of PALA resistance (Chernova et al., 1995) . Cells that are already in S phase when the eects of PALA are manifest eventually arrest in G2/ M, which inhibits the segregation of DNA synthesized under unfavorable conditions. The G2/M arrest is presumably a fail-safe mechanism since, even if such cells did not complete mitosis, their broken DNA would cause them to arrest in the subsequent G1 (Di Leonardo et al., 1994) . In cells completely lacking p53, neither the G1/S nor G2/M checkpoints function in PALA, leading both to DNA synthesis from highly imbalanced pools of deoxynucleotides and to the segregation of damaged DNA. There is evidence that, even after entering S phase in PALA, p53 can inhibit DNA ampli®cation and the emergence of PALAresistant cells. We have recently found two cell lines which, although not permissive for PALA resistance, still fail to arrest in G1 when treated with PALA (Agarwal et al., 1998a : Chernova et al., 1998 . However, in these cells, p53 inhibits progression through S phase, preventing the cells from incurring DNA damage through a mechanism dierent from those that are important in normal cells.
A potential mechanism of inhibition of mitotic entry by p53 is suggested by observations made with extracts from cycling Xenopus cells. Although p21/waf1/cip1 is a poor inhibitor of the G2/M kinase CDC2, full activation of CDC2 requires active CDK2, which is inhibited eciently by p21/waf1/cip1 (Harper et al., 1995; Guadagno and Newport, 1996) . Furthermore, recent evidence has shown that p21/waf1/cip1 can inhibit entry into mitosis when overexpressed (Cayrol et al., 1998; Dulic et al., 1998; Medema et al., 1998; Niculescu et al., 1998) . Therefore p21/waf1/cip1 may contribute to the G2 arrest induced by p53. There is recent evidence for a potential p21/waf1/cip1-independent pathway that inhibits G2/M progression when the p53 pathway is activated. p53 has recently been shown to transactivate directly the gene encoding the 14-3-3s protein (Hermeking et al., 1997) . 14-3-3 proteins are capable of binding to CDC25, possibly forming an inactive complex no longer capable of activating CDC2 (Peng et al., 1997) . Thus, p53 transactivates two genes, p21/waf1/cip1, and 14-3-3s, both capable of blocking entry into mitosis possibly by regulating the activity of CDC2. The relative contribution of these two targets to the G2 arrest mediated by p53 under dierent conditions is yet to be determined. However, we have recently found that 14-3-3s, although abundantly expressed in epithelial cells, was not detected in human ®broblast cells under conditions where p53 is highly induced and transcriptionally active (Taylor et al., manuscript in preparation) . This result suggests that 14-3-3s may not mediate the eects of p53 on the G2/M transition in ®broblast cells.
We have recently analysed CDC2 kinase activity in TR9-7 cells arrested in G2 by p53 overexpression, using the mimosine-release protocol described in Figure 7 , and have found that it is highly reduced (Taylor et al., manuscript in preparation), suggesting that inhibition of CDC2 may mediate G2 arrest by p53, consistent with ability of caeine to overcome the G2 block induced by p53 overexpression.
It is well established that p53-mediated arrest in G1 is an important cellular response to DNA damage (Kastan et al., 1991; Dulic et al., 1994) . Our results now show that p53 is involved in regulating the G2/M transition in response to genotoxic stress. In particular, the p53-dependent inhibition of mitotic entry when DNA synthesis is blocked probably re¯ects a physiologically important stress response, perhaps required to avoid premature mitotic entry when DNA synthesis is arrested transiently, for example, by UV damage during S phase, or by hypoxia when rapidly growing cells outrace their blood supply or during wound healing (Anderson et al., 1995) . In addition, an ecient block to mitotic entry in cells that have synthesized DNA under unfavorable conditions is likely to be important in preventing the propagation of damaged DNA.
Materials and methods
Cell lines and culture conditions
Cells were grown in a humidi®ed atmosphere containing 10% CO 2 in Dulbecco's minimal essential medium (Gibco, Grand Island, NY, USA), supplemented with antibiotics and 10% fetal bovine serum (Gibco). WI38 cells were obtained from the American Type Culture Collection (Rockville, MD, USA). MDAH041, a spontaneously immortalized Li-Fraumeni skin ®broblast cell line, was obtained from M Tainsky (MD Anderson Cancer Center).
The TR9-7 cell line, expressing a tetracycline regulated p53 cDNA, was derived from MDAH041 cells . p53-null MEFs obtained from L Donehower (Baylor College of Medicine) were used at passage four. In order to analyse DNA content and immuno¯uorescence in the same experiment (Figure 7 ), cells were plated on 10-cm dishes containing coverslips. At the times speci®ed, the cells on the coverslips were ®xed and the remaining cells were analysed for cell cycle distribution by FACScanning. FACS data were analysed using CELLFIT software (Becton Dickinson).
DNA synthesis
BrdU (Amersham) was added to cells for 2 h following treatment with the inhibitors. The cells were ®xed with 7% ethanol at 7208C, DNA was denatured with 0.5% Triton X-100 (v/v) in 2 M HCl, followed by neutralization with 0.1 M Na 2 B 4 0 7 , pH 8.5. BrdU incorporation was detected by staining cells with¯uorescein isothiocyanate-conjugated anti-BrdU (Becton Dickinson). Cells counterstained with propidium iodide (5 mg/ml) were evaluated by twoparameter FACS separation and the data were analysed using CELLFIT software (Becton Dickinson).
Western analysis
Western transfers onto polyvinylidene di¯uoride membranes (Millipore) were prepared from whole-cell extracts after separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12.5% acrylamide). Protein concentrations of lysates were determined by the Bradford method (Biorad) and equal quantities of protein were loaded for each sample. To detect p53, cells were lysed in 20 mM Tris (pH 7.5), 2% SDS, 2 mM benzamidine, and 0.2 mM phenylmethyl sulfonyl¯uoride (PMSF) and the membranes were probed with the DO-1 monoclonal antibody (Santa Cruz), which was detected with a goat-anti-mouse antibody conjugated to horseradish peroxidase (Boehringer Mannheim), using enhanced chemiluminescence (Dupont; Agarwal et al., 1995) .
Immuno¯uorescence
Immuno¯uorescence assays were carried out as previously described (Chadee et al., 1995) . Brie¯y, cells on coverslips were treated with 2% formaldehyde in phosphate buered saline (PBS), followed by methanol. Phosphorylated histone H1b was detected with an antiserum to the phosphorylated protein (Lu et al., 1994; Chadee et al., 1995) . To detect mitotic spindles, cells were ®xed with 3.5% formaldehyde in 10 mM sodium phosphate (pH 7.4), 150 mM NaCl, 1 mM EGTA and 0.01% NaN 3 (w/v), permeabilized with 150 mM NaCl, 10 mM Tris (pH 7.7), 0.1% Triton X-100 (v/v) and 0.1% bovine serum albumin (w/v) and stained with an antibody to a-tubulin (Sigma) (Bernat et al., 1990) . Speci®c staining was detected with uorescein isothiocyanate-conjugated secondary antibodies (Sigma), and DNA was counterstained with DAPI (4 mg/ ml). Double staining was carried out with Lissamine rhodamine sulfonyl chloride-conjugated anti-rabbit secondary antibodies (Jackson Immunoresearch). Antibody binding was carried out for 1.5 h at 378C in PBS containing 0.1% bovine serum albumin (w/v) and 0.02% NaN 3 (w/v). Coverslips were mounted with Citi¯uor (Citi¯uor, Ltd.) and photographed using Oncor software. Data were compared with two-tailed paired Student's t-test.
DNA content of mitotic cells
Two-parameter FACS analysis was based on methods used for quantitative detection of other intracellular antigens (reviewed by Jacobberger, 1991). Cells harvested by trypsinization (including¯oating cells) were washed twice with phosphate buered saline and ®xed by dropping them into 70% ethanol at 7208C. Similar results were obtained when cells were ®xed with 2% formaldehyde in PBS, followed by methanol. The cells were resuspended in 0.1% bovine serum albumin (w/v), 0.02% NaN 3 (w/v) in PBS, incubated at room temperature for 30 min, and stained with an antiserum against pH1b, after which the cells were washed once with the same buer and stained with a goat anti-rabbit antibody labeled with¯uorescein isothiocyanate (Sigma). The cells were washed, counterstained with a solution containing propidium iodide (50 mg/ml) and RNAse (2 units/ml) and analysed by two-parameter FACScanning. Twenty thousand cells were analysed for each condition.
Time-lapse analysis of mitosis
Time-lapse video microscopy utilized the NIH Image software program to capture a series of individual frames every 6 min (Figure 1c) or every 16 min, 40 s (Figure 1a and b) to generate a movie. Video images were captured using a Sony XC-77 black-and-white CCD camera with a Scion LG-3 frame capture board in a Macintosh computer.
Cells were maintained on an inverted microscope with a warming stage covered by a glass environmental jar, heated to avoid condensation. The cells were maintained in a 5% carbon dioxide atmosphere and viewed under phase contrast. For a cell to be scored as mitotic, it had to have entered metaphase and then re-entered interphase, with or without cytokinesis. Metaphase was characterized by loss of almost all contact with the substratum, resulting in the formation of a smooth, round cell. Interphase was characterized by reattachment to the substratum and the acquisition of a ®broblastic morphology.
